BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 32630842)

  • 1. CMH-Small Molecule Docks into SIRT1, Elicits Human IPF-Lung Fibroblast Cell Death, Inhibits Ku70-deacetylation, FLIP and Experimental Pulmonary Fibrosis.
    Konikov-Rozenman J; Breuer R; Kaminski N; Wallach-Dayan SB
    Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32630842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SIRT1 Deficiency, Specifically in Fibroblasts, Decreases Apoptosis Resistance and Is Associated with Resolution of Lung-Fibrosis.
    Bulvik R; Breuer R; Dvir-Ginzberg M; Reich E; Berkman N; Wallach-Dayan SB
    Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32630813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forefront: MiR-34a-Knockout Mice with Wild Type Hematopoietic Cells, Retain Persistent Fibrosis Following Lung Injury.
    Bulvik R; Biton M; Berkman N; Breuer R; Wallach-Dayan SB
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ku70 acetylation and modulation of c-Myc/ATF4/CHOP signaling axis by SIRT1 inhibition lead to sensitization of HepG2 cells to TRAIL through induction of DR5 and down-regulation of c-FLIP.
    Kim MJ; Hong KS; Kim HB; Lee SH; Bae JH; Kim DW; Dao TT; Oh WK; Kang CD; Kim SH
    Int J Biochem Cell Biol; 2013 Mar; 45(3):711-23. PubMed ID: 23247197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compartmentalized expression of c-FLIP in lung tissues of patients with idiopathic pulmonary fibrosis.
    Cha SI; Groshong SD; Frankel SK; Edelman BL; Cosgrove GP; Terry-Powers JL; Remigio LK; Curran-Everett D; Brown KK; Cool CD; Riches DW
    Am J Respir Cell Mol Biol; 2010 Feb; 42(2):140-8. PubMed ID: 19372246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of an acetylation-dependant Ku70/FLIP complex that regulates FLIP expression and HDAC inhibitor-induced apoptosis.
    Kerr E; Holohan C; McLaughlin KM; Majkut J; Dolan S; Redmond K; Riley J; McLaughlin K; Stasik I; Crudden M; Van Schaeybroeck S; Fenning C; O'Connor R; Kiely P; Sgobba M; Haigh D; Johnston PG; Longley DB
    Cell Death Differ; 2012 Aug; 19(8):1317-27. PubMed ID: 22322857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4-(4-Chloro-2-methylphenoxy)-N-hydroxybutanamide (CMH) targets mRNA of the c-FLIP variants and induces apoptosis in MCF-7 human breast cancer cells.
    Bijangi-Vishehsaraei K; Huang S; Safa AR; Saadatzadeh MR; Murphy MP
    Mol Cell Biochem; 2010 Sep; 342(1-2):133-142. PubMed ID: 20446019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
    Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
    PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice.
    Sanders YY; Hagood JS; Liu H; Zhang W; Ambalavanan N; Thannickal VJ
    Eur Respir J; 2014 May; 43(5):1448-58. PubMed ID: 24603818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular FLICE-like inhibitory protein deviates myofibroblast fas-induced apoptosis toward proliferation during lung fibrosis.
    Golan-Gerstl R; Wallach-Dayan SB; Zisman P; Cardoso WV; Goldstein RH; Breuer R
    Am J Respir Cell Mol Biol; 2012 Sep; 47(3):271-9. PubMed ID: 22582174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein Tyrosine Phosphatase-N13 Promotes Myofibroblast Resistance to Apoptosis in Idiopathic Pulmonary Fibrosis.
    Bamberg A; Redente EF; Groshong SD; Tuder RM; Cool CD; Keith RC; Edelman BL; Black BP; Cosgrove GP; Wynes MW; Curran-Everett D; De Langhe S; Ortiz LA; Thorburn A; Riches DWH
    Am J Respir Crit Care Med; 2018 Oct; 198(7):914-927. PubMed ID: 29727583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of RGS2: a new mechanism for pirfenidone amelioration of pulmonary fibrosis.
    Xie Y; Jiang H; Zhang Q; Mehrotra S; Abel PW; Toews ML; Wolff DW; Rennard S; Panettieri RA; Casale TB; Tu Y
    Respir Res; 2016 Aug; 17(1):103. PubMed ID: 27549302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hsp90 regulation of fibroblast activation in pulmonary fibrosis.
    Sontake V; Wang Y; Kasam RK; Sinner D; Reddy GB; Naren AP; McCormack FX; White ES; Jegga AG; Madala SK
    JCI Insight; 2017 Feb; 2(4):e91454. PubMed ID: 28239659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LTBP2 is secreted from lung myofibroblasts and is a potential biomarker for idiopathic pulmonary fibrosis.
    Enomoto Y; Matsushima S; Shibata K; Aoshima Y; Yagi H; Meguro S; Kawasaki H; Kosugi I; Fujisawa T; Enomoto N; Inui N; Nakamura Y; Suda T; Iwashita T
    Clin Sci (Lond); 2018 Jul; 132(14):1565-1580. PubMed ID: 30006483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SIRT1 inhibition impairs non-homologous end joining DNA damage repair by increasing Ku70 acetylation in chronic myeloid leukemia cells.
    Zhang W; Wu H; Yang M; Ye S; Li L; Zhang H; Hu J; Wang X; Xu J; Liang A
    Oncotarget; 2016 Mar; 7(12):13538-50. PubMed ID: 26646449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SIRT1 promotes DNA repair activity and deacetylation of Ku70.
    Jeong J; Juhn K; Lee H; Kim SH; Min BH; Lee KM; Cho MH; Park GH; Lee KH
    Exp Mol Med; 2007 Feb; 39(1):8-13. PubMed ID: 17334224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of Fas signaling in fibroblasts impairs homeostatic fibrosis resolution and promotes persistent pulmonary fibrosis.
    Redente EF; Chakraborty S; Sajuthi S; Black BP; Edelman BL; Seibold MA; Riches DW
    JCI Insight; 2020 Dec; 6(1):. PubMed ID: 33290280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis.
    Korfei M; Stelmaszek D; MacKenzie B; Skwarna S; Chillappagari S; Bach AC; Ruppert C; Saito S; Mahavadi P; Klepetko W; Fink L; Seeger W; Lasky JA; Pullamsetti SS; Krämer OH; Guenther A
    PLoS One; 2018; 13(11):e0207915. PubMed ID: 30481203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the stem cell factor 248 isoform attenuates the development of pulmonary remodeling disease.
    Rasky A; Habiel DM; Morris S; Schaller M; Moore BB; Phan S; Kunkel SL; Phillips M; Hogaboam C; Lukacs NW
    Am J Physiol Lung Cell Mol Physiol; 2020 Jan; 318(1):L200-L211. PubMed ID: 31747308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
    Zhang L; Li Y; Liang C; Yang W
    Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.